Kaup Síldarvinnslunnar á Ice Fresh Seafood ehf. ganga til baka
June 02, 2024 16:31 ET
|
Sildarvinnslan ltd
Stjórn Síldarvinnslunnar hf. hefur samþykkt beiðni Samherja hf. um að kaup félagsins á helmingshlut í sölufyrirtækinu Ice Fresh Seafood ehf. gangi til baka. Tilkynnt var um kaupin 26. september í...
Biognosys lance P2 Plasma Enrichment, une technologie révolutionnaire pour la protéomique approfondie et non biaisée du plasma à la conférence de l’ASMS 2024
June 02, 2024 16:08 ET
|
Biognosys AG
La méthode exclusive P2 Plasma Enrichment s’appuie sur une nouvelle méthode d’enrichissement du plasma à un seul puits et à une seule particule pour obtenir les meilleures performances du marché en...
Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 2024 ASCO® Annual Meeting
June 02, 2024 12:30 ET
|
Merus N.V.
UTRECHT, The Netherlands and CAMBRIDGE, Mass., June 02, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative,...
Merus : présentation des données provisoires sur le MCLA-145 en monothérapie et en association avec le pembrolizumab lors du congrès annuel 2024 de l’ASCO®
June 02, 2024 12:30 ET
|
Merus N.V.
UTRECHT, Pays-Bas et CAMBRIDGE, État du Massachusetts, 02 juin 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), ci-après « Merus, la Société, nous, ou notre », une société spécialisée dans...
KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
June 02, 2024 11:31 ET
|
King Faisal Specialist Hospital & Research Centre
KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
Flash News: OKX Now Supports Wormhole Protocol's W Token on Ethereum Mainnet
June 02, 2024 11:27 ET
|
OKX
DUBAI, United Arab Emirates, June 02, 2024 (GLOBE NEWSWIRE) -- OKX, a leading crypto exchange and Web3 technology company, has issued updates for June 2, 2024. OKX Now Supports Wormhole Protocol's...
Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Early Cancer Detection Study
June 02, 2024 10:55 ET
|
Seer, Inc.
REDWOOD CITY, Calif., June 02, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, announced today that...
Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT-Activated NBTXR3 Followed By anti-PD-1 For 2l+ R/M HNSCC Naïve or Resistant to Prior anti-PD-1 Therapy
June 02, 2024 10:00 ET
|
Nanobiotix S.A.
Data show favorable safety and feasibility in 68 heavily pre-treated patients with R/M-HNSCC (Intention-to-Treat population; “ITT”) who received RT-activated NBTXR3 followed by anti-PD-1 as a...
Precede Biosciences Presents New Data at ASCO 2024 Demonstrating Accurate HER2 Status Detection Across Multiple Cancers and the Ability to Quantify ER Pathway Activation in Breast Cancer from a Simple Blood Test
June 02, 2024 10:00 ET
|
Precede Biosciences, Inc.
HER2 status was accurately assessed in 172 patients with advanced breast, gastroesophageal, and ovarian cancersER status was accurately assessed and the level of ER pathway activation quantified in 87...
ALX Oncology Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1 ASPEN-07 Clinical Trial in Patients with Advanced Bladder Cancer
June 02, 2024 10:00 ET
|
ALX Oncology
Evorpacept in combination with PADCEV®, an approved antibody-drug conjugate (“ADC”), demonstrated promising activity and was generally well toleratedCompany to host conference call and webcast with...
- June 02, 2024 11:31 ET KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
- June 02, 2024 10:00 ET Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT-Activated NBTXR3 Followed By anti-PD-1 For 2l+ R/M HNSCC Naïve or Resistant to Prior anti-PD-1 Therapy